Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

NCT03068481 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: KDT-3594
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.